Kurniawan Suhartono - Kalbe Farma Head Unit
| KLBF Stock | IDR 1,480 20.00 1.33% |
Insider
Kurniawan Suhartono is Head Unit of Kalbe Farma Tbk
| Age | 58 |
| Phone | 62 21 4287 3888 |
| Web | https://www.kalbe.co.id |
Kalbe Farma Management Efficiency
The company has return on total asset (ROA) of 0.106 % which means that it generated a profit of $0.106 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1673 %, meaning that it generated $0.1673 on every $100 dollars invested by stockholders. Kalbe Farma's management efficiency ratios could be used to measure how well Kalbe Farma manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Munni Chairunisa | Surya Citra Media | N/A | |
| Paulus Sujono | Siloam International Hospitals | N/A | |
| Joel Ellis | Siloam International Hospitals | 37 | |
| Hendra Wijaya | Erajaya Swasembada Tbk | 41 | |
| Amelia Hendra | Siloam International Hospitals | N/A | |
| Hari Gurung | Tower Bersama Infrastructure | N/A | |
| Yogi Pamungkas | Tower Bersama Infrastructure | N/A | |
| Endah Jati | Surya Citra Media | N/A | |
| David CPA | Merdeka Copper Gold | 57 | |
| Supriatno Arham | Tower Bersama Infrastructure | 50 | |
| Darjoto BSc | Siloam International Hospitals | 65 | |
| Ika Pasaribu | Surya Citra Media | N/A | |
| Douglas Jones | Merdeka Copper Gold | N/A | |
| Helmy Santoso | Tower Bersama Infrastructure | 47 | |
| Adrian Anwar | Surya Citra Media | N/A | |
| Ravinder Mawa | Surya Citra Media | N/A | |
| Robert Sihombing | Surya Citra Media | N/A | |
| Lie An | Tower Bersama Infrastructure | N/A | |
| Boyke BSc | Merdeka Copper Gold | 59 | |
| Eric Rahardja | Merdeka Copper Gold | 40 | |
| Maria | Siloam International Hospitals | N/A | |
Management Performance
| Return On Equity | 0.17 | |||
| Return On Asset | 0.11 |
Kalbe Farma Tbk Leadership Team
Elected by the shareholders, the Kalbe Farma's board of directors comprises two types of representatives: Kalbe Farma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Kalbe. The board's role is to monitor Kalbe Farma's management team and ensure that shareholders' interests are well served. Kalbe Farma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Kalbe Farma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Lanny Soputro, G HR | ||
| Vidjongtius, Director, Corporate Secretary, IR Contact Officer | ||
| Kurniawan Suhartono, Head Unit | ||
| Sie Djohan, Management Devel | ||
| Lukito Gozali, Head Relations |
Kalbe Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Kalbe Farma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.17 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 0.15 % | |||
| Current Valuation | 95.3 T | |||
| Shares Outstanding | 46.26 B | |||
| Shares Owned By Insiders | 58.08 % | |||
| Shares Owned By Institutions | 15.23 % | |||
| Price To Book | 5.06 X | |||
| Price To Sales | 3.36 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Kalbe Stock
Kalbe Farma financial ratios help investors to determine whether Kalbe Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kalbe with respect to the benefits of owning Kalbe Farma security.